Award
NIH Reporter #5R01HL163419-03
Role of carnosine in peripheral arterial disease
Recipient
Not Specified
Award Amount
$632,838.00
Ceiling
$632,838.00
Awarded
July 09, 2026
Identifier
5R01HL163419-03
Award for clinical trials studying carnosine supplementation in peripheral arterial disease patients, funded by NHLBI with $632,838 over nearly 5 years.
Description
This project involves clinical trials to evaluate the efficacy of carnosine supplementation in patients with peripheral arterial disease. The award amount is approximately $632,838, with a project duration from August 15, 2024, to May 31, 2029. The project is funded by the NHLBI and is part of the NIH grants program.